Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | $577.89 | $224.30 | 157.64% | 38.19x | 43.38x | 7,315.06x | 5.88x | 1.44x | -$91.90M | -0.27% | $5.98B | 99.85 | $33.53B | 293.27 | ||
| CRMD | CORMEDIX INC | $14.56 | $11.89 | 22.43% | 56.00x | 15.66x | 11.51x | 8.60x | 0.49x | -$13.63M | -1.44% | $114.89M | 1.76 | $921.72M | 52.17 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.99 | $5.50 | 45.32% | 99.88x | 19.02x | 6.86x | 11.00x | 0.56x | -$8.51M | -1.23% | $68.12M | 0.79 | $735.66M | 55.09 | ||
| TGTX | TG THERAPEUTICS INC | $36.01 | $11.74 | 206.72% | 133.37x | 40.14x | 13.67x | 24.09x | 1.23x | -$61.10M | -1.16% | $237.29M | 1.62 | $5.84B | 82.88 | ||
| CORT | CORCEPT THERAPEUTICS INC | $70.06 | $30.60 | 128.98% | 55.17x | 50.31x | 10.64x | 10.87x | 1.04x | $177.16M | 2.43% | $683.29M | 6.56 | $7.35B | 66.20 | ||
| RPRX | ROYALTY PHARMA PLC | $34.84 | $47.58 | -26.78% | 14.11x | 7.73x | 6.70x | 2.00x | 0.36x | $2.58B | 16.97% | $9.79B | 22.48 | $26.12B | 19.50 | ||
| VCEL | VERICEL CORP | $42.67 | $3.72 | 1,046.41% | 853.40x | 162.06x | 8.93x | 7.27x | 4.35x | -$6.61M | -0.31% | $295.49M | 5.92 | $2.17B | 128.90 | ||
| KRYS | KRYSTAL BIOTECH INC | $137.07 | $79.00 | 73.50% | 31.73x | 24.07x | 11.84x | 4.02x | 0.87x | $129.75M | 3.29% | $984.67M | 34.17 | $3.66B | 25.30 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $8.18 | $8.13 | 0.61% | 28.21x | 13.86x | 4.60x | 3.16x | 0.44x | $64.00M | 5.64% | $350.19M | 2.52 | $1.12B | 16.95 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.97 | $36.59 | -9.88% | 12.35x | 10.74x | 2.54x | 2.63x | 0.53x | $221.39M | 11.72% | $720.53M | 12.57 | $1.58B | 6.64 | ||
| HALO | HALOZYME THERAPEUTICS INC | $53.98 | $47.41 | 13.85% | 14.02x | 10.46x | 6.13x | 13.79x | 0.72x | $495.76M | 7.45% | $482.27M | 3.91 | $7.98B | 11.33 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.53 | $18.79 | 25.22% | 14.26x | 10.88x | 5.35x | 3.61x | 0.85x | $267.57M | 9.36% | $794.28M | 6.54 | $2.29B | 7.73 | ||
| INCY | INCYTE CORP | $67.75 | $21.68 | 212.49% | 233.62x | 14.26x | 2.97x | 3.58x | 1.19x | $302.71M | 2.31% | $3.67B | 18.93 | $11.21B | 27.55 | ||
| ADMA | ADMA BIOLOGICS INC | $20.81 | $9.16 | 127.20% | 23.65x | 31.29x | 10.77x | 13.30x | 1.70x | $90.64M | 1.83% | $373.42M | 1.57 | $4.97B | 30.91 | ||
| MNKD | MANNKIND CORP | $3.71 | $1.99 | 86.38% | 37.10x | 20.24x | 3.78x | -19.24x | 0.91x | $21.82M | 1.94% | -$58.62M | -0.19 | $1.37B | 16.56 | ||
| EXEL | EXELIXIS INC | $41.59 | $24.68 | 68.51% | 18.48x | 17.88x | 5.04x | 5.32x | 1.19x | $820.89M | 7.08% | $2.13B | 7.64 | $11.35B | 12.68 | ||
| NVO | NOVO NORDISK A S | $79.83 | $37.99 | 110.16% | 22.37x | 20.81x | 7.75x | 16.96x | 1.53x | $12.01B | 3.37% | $21.02B | 4.71 | $368.55B | 15.94 | ||
| MDXG | MIMEDX GROUP INC | $6.04 | $4.89 | 23.48% | 22.37x | 23.23x | 2.52x | 4.40x | 0.62x | $64.60M | 7.27% | $202.78M | 1.38 | $804.35M | 12.70 | ||
| TECH | BIO-TECHNE CORP | $50.52 | $17.87 | 182.75% | 60.87x | 30.36x | 6.58x | 3.92x | 1.34x | $220.76M | 2.78% | $2.02B | 12.82 | $8.20B | 28.33 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $108.50 | $175.79 | -38.28% | 13.93x | 52.61x | 1.63x | 1.60x | 0.29x | $1.51B | 22.87% | $4.17B | 68.46 | $10.23B | 8.19 | ||
| VCYT | VERACYTE INC | $26.44 | $9.08 | 191.05% | 61.49x | 32.74x | 4.45x | 1.73x | 1.38x | $78.45M | 3.80% | $1.19B | 15.31 | $1.93B | 30.67 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.22 | $38.31 | 46.74% | 20.44x | 16.16x | 3.64x | 1.86x | 0.85x | $624.18M | 5.81% | $5.79B | 30.34 | $10.33B | 13.29 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $13.63 | $1.45 | 840.89% | 75.72x | 107.58x | 9.83x | 19.40x | 10.49x | $19.56M | 1.84% | $55.35M | 0.71 | $1.02B | 63.69 | ||
| GMAB | GENMAB A | $22.82 | $16.76 | 36.16% | 13.17x | 15.72x | 4.80x | 2.85x | 1.11x | $1.09B | 7.24% | $5.30B | 8.00 | $13.62B | N/A | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $21.71 | $8.64 | 151.40% | 15.73x | 43.58x | 3.63x | 4.75x | 7.41x | $148.44M | 4.10% | $765.24M | 4.59 | $3.45B | 12.41 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.